Millon Behavioral Medicine Diagnostic (MBMD) predicts health-related quality of life (HrQoL) over time among men treated for localized prostate cancer

Dean G. Cruess, Catherine Benedict, Emily G. Lattie, Ivan Molton, Dave Kinsinger, Bruce Kava, Murugesan Manoharan, Mark Soloway, Frank J. Penedo*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

9 Scopus citations

Fingerprint

Dive into the research topics of 'Millon Behavioral Medicine Diagnostic (MBMD) predicts health-related quality of life (HrQoL) over time among men treated for localized prostate cancer'. Together they form a unique fingerprint.

Social Sciences

Medicine & Life Sciences

Chemical Compounds